NYSE:THCHealthcare
Tenet Healthcare (THC) Raised Full Year Guidance, Does It Look Fairly Valued?
Tenet Healthcare (THC) is back on investors' radar after second quarter 2026 earnings and new full year guidance pointed to stronger profitability, higher revenue expectations and a larger share repurchase program.
See our latest analysis for Tenet Healthcare.
The latest earnings and guidance reset have clearly shifted sentiment, with Tenet Healthcare’s share price up 17.17% on the day and posting a 25.69% 3 month share price return. The 1 year total shareholder return of 52.40% and 3 year...